A new variant of COVID-19, named BA.3.2 but nicknamed “cicada,” is gaining attention for its multiple mutations. While it has caused only a few cases in the U.S., it is spreading in Europe, prompting concerns in North America. The variant was first identified in South Africa and has since been detected in several states in the U.S. Experts are monitoring its spread and impact, but it is still considered a minority strain.
There is uncertainty about whether the cicada variant is more severe than other strains, as early data suggests it behaves similarly to previous variants. There are concerns that it may evade the immune defenses generated by vaccines and previous infections. However, vaccines are likely to provide some protection against severe illness caused by the variant.
Public health officials recommend annual COVID-19 vaccinations to stay protected against evolving strains. The current vaccine formulation is effective until fall 2026 and may include coverage for the cicada variant. At-home COVID-19 tests should still detect the variant, as they target stable components of the virus. It is important to follow testing guidelines and seek medical advice if experiencing symptoms.
As new variants emerge, it is crucial for individuals to stay informed and follow health guidelines to protect themselves and others from the evolving threat of COVID-19.
